In a significant step forward for workplace safety and digital health diagnostics, biotech company MindBio Therapeutics (CSE:MBIO) has announced the development of a novel fatigue prediction model powered by artificial intelligence and speech analytics—technology the company claims could redefine how impairment is detected across high-risk industries.
The Vancouver-based biotechnology firm revealed that its proprietary AI platform can analyze subtle changes in human voice patterns to detect fatigue, alongside drug and alcohol impairment, in real time.
Click here for the full story.
Top cannabis news stories
1 | MediPharm Labs reports first quarter 2026 results, achieving positive adjusted EBITDA
2 | Auxly reports first quarter 2026 results: Net revenue increase of 22 per cent
3 | Charlotte’s Web first quarter 2026 financial results: Year-over-year SG&A declined 17.7 per cent
4 | Cronos Group reports 2026 first quarter results: Net revenue increased by 40 per cent year-over-year
Top Cannabis Stocks May 8 to May 14, 2026
1. T.CURA | 7,476 views | Curaleaf Holdings Inc.
2. T.TLRY | 2,561 views | Tilray Brands Inc.
3. T.LABS | 2,512 views | Medipharm Labs Corp.
4. T.OGI | 853 views | Organigram Global Inc.
5. C.TGIF | 578 views | 1933 Industries Inc.
6. C.BLO | 251 views | Cannabix Technologies Inc.
